$9M ASAP (Aligning Science Across Parkinson’s) grant The Khurana lab and collaborators have been selected…
Yeast Reveals New Drug Target for Parkinson’s
Many progressive neurodegenerative disorders like Alzheimer’s, Huntington’s, and Parkinson’s disease, are characterized by abnormal clumps of proteins that clog up the cell and disrupt normal cellular functions. But it’s difficult to study these complex disease processes directly in the brain—so NIH-funded researchers, led by a team at the Whitehead Institute for Biomedical Research, Cambridge, MA, have turned to yeast for help.